SUNY-Stony Brook: Drug Designed to Treat Neuropathy Advances in Clinical Trials
January 18, 2025
January 18, 2025
STONY BROOK, New York, Jan. 18 (TNSres) -- The State University of New York's Stony Brook University issued the following news release:
* * *
A compound originally developed at Stony Brook now in clinical development by Artelo Biosciences completes safety review
* * *
A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committ . . .
* * *
A compound originally developed at Stony Brook now in clinical development by Artelo Biosciences completes safety review
* * *
A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committ . . .